Prognostic significance of primary tumor localization in stage II and III colon cancer

doi:10.4251/wjgo.v10.i11.410

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7921)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

348

WORD

179

HTML

2854

Figures (1-3)

516

Tables (1-4)

212

Sum=4109

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

663

Download

830

Sum=1493

Publishing Process of This Article

Item

Count

Browse

980

Download

1339

Sum=2319

Nov 15, 2018 (publication date) through Oct 4, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Nov 15, 2018; 10(11): 410-420
Published online Nov 15, 2018. doi: 10.4251/wjgo.v10.i11.410

Open in New Tab Full Size Figure Download Figure

Figure 1 Disease free survival by primary tumor localization in Kaplan-Meier analysis. A: Stage II patients not receiving adjuvant therapy; B: Stage II patients receiving adjuvant therapy; C: Stage III patients not receiving adjuvant therapy; D: Stage III patients receiving adjuvant therapy; E: Stage III patients receiving adjuvant 5-fluorouracil based therapy; F: Stage III patients receiving adjuvant oxaliplatin based therapy. 5-FU: 5-Fluorouracil; DFS: Disease free survival; LCC: Left colon cancer; n: Number of patients; RCC: Right colon cancer.

Open in New Tab Full Size Figure Download Figure

Figure 2 Overall survival by primary tumor localization in Kaplan-Meier analysis. A: Stage II patients not receiving adjuvant therapy; B: Stage II patients receiving adjuvant therapy; C: Stage III patients not receiving adjuvant therapy; D: Stage III patients receiving adjuvant therapy; E: Stage III patients receiving adjuvant 5-fluorouracil based therapy; F: Stage III patients receiving adjuvant oxaliplatin based therapy. 5-FU: 5-Fluorouracil; LCC: Left colon cancer; n: Number of patients; OS: Overall survival; RCC: Right colon cancer.

Open in New Tab Full Size Figure Download Figure

Figure 3 The overall survival effect of tumor localization after recurrence. LCC: Left colon cancer; OS2: Overall survival after recurrence; RCC: Right colon cancer; n: number of patients.

Citation: Sakin A, Arici S, Secmeler S, Can O, Geredeli C, Yasar N, Demir C, Demir OG, Cihan S. Prognostic significance of primary tumor localization in stage II and III colon cancer. World J Gastrointest Oncol 2018; 10(11): 410-420
URL: https://www.wjgnet.com/1948-5204/full/v10/i11/410.htm
DOI: https://dx.doi.org/10.4251/wjgo.v10.i11.410